NYSE$OGEN
Oragenics Inc · Q1 2024 earnings
Q1 2024 earnings · · Investor relations
Briefing
OGEN Q1 2024 — n/d revenue, 3.00 EPS
March 31, 2024 are not necessarily indicative of the results of operations that may be expected for the year ended December 31,. Oragenics Inc reported Q1 2024 results. Diluted EPS came in at $3.00. Net income of $2.5M. Headline numbers extracted from the Form 10-Q press release; narrative is light because this row was processed without an LLM call.
- Diluted EPS: $3.00.
- Net income: $2.5M.
- Filed on Form 10-Q (accession 0001493152-24-019655).
Headline financials
Revenue & EPS history
Oragenics · Revenue · Quarterly
$0
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q1 2024
-1.0%
Avg return
Earnings day
+0.9%
Avg return
5 days after
-6.4%
Avg return
30 days after
25%
16 / 64 earnings
Positive
+92.6%
Q2 2024
Best reaction
-37.3%
Q2 2011
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q4 2026 | +0.0% | -5.0% | — | |
| Q3 2025 | +0.0% | +1.8% | -12.5% | |
| Q2 2025 | -1.7% | -6.0% | +3.4% | |
| Q1 2025 | +0.0% | -5.0% | -38.2% | |
| Q4 2024 | -2.8% | -4.5% | -13.6% | |
| Q3 2024 | -9.6% | -19.4% | -8.3% | |
| Q2 2024 | +92.6% | +66.7% | -51.9% | |
| Q1 2024 | -0.6% | +86.1% | -0.6% | |
| Q4 2023 | -0.7% | -8.3% | -28.5% | |
| Q3 2023 | -5.0% | -5.3% | +29.6% | |
| Q2 2023 | -4.7% | -8.2% | -5.6% | |
| Q1 2023 | -4.5% | -7.8% | -4.1% | |
| Q4 2022 | +3.5% | +2.9% | -6.1% | |
| Q3 2022 | +7.1% | +0.0% | -15.0% | |
| Q2 2022 | -1.8% | +0.0% | -26.3% | |
| Q1 2022 | -1.0% | -8.6% | -5.7% | |
| Q4 2021 | -8.6% | -5.4% | -5.4% | |
| Q3 2021 | -6.0% | -9.7% | -27.4% | |
| Q2 2021 | -0.8% | -4.5% | -3.0% | |
| Q1 2021 | -7.6% | -17.5% | -11.3% | |
| Q4 2020 | +2.0% | -19.6% | -10.8% | |
| Q3 2020 | +4.6% | +0.0% | -4.3% | |
| Q2 2020 | -4.4% | -11.2% | -34.7% | |
| Q1 2020 | -2.4% | +14.5% | +1.8% | |
| Q4 2019 | -0.7% | -11.8% | -19.1% | |
| Q3 2019 | +6.4% | +10.9% | +13.0% | |
| Q2 2019 | -3.5% | +0.0% | +47.4% | |
| Q1 2019 | -3.4% | -6.0% | -2.0% | |
| Q4 2018 | -2.1% | -1.6% | -9.8% | |
| Q3 2018 | -12.9% | -2.1% | -2.1% | |
| Q2 2018 | -1.8% | -16.0% | -4.0% | |
| Q1 2018 | +0.8% | -3.3% | +16.7% | |
| Q4 2017 | -7.4% | -9.4% | -0.5% | |
| Q3 2017 | -10.6% | -5.6% | +11.1% | |
| Q2 2017 | -0.0% | +6.1% | +15.2% | |
| Q1 2017 | +31.1% | +36.8% | +2.6% | |
| Q4 2016 | -1.6% | -1.6% | -31.7% | |
| Q3 2016 | +2.2% | -4.4% | +28.9% | |
| Q2 2016 | -8.5% | +15.5% | -29.6% | |
| Q1 2016 | -20.2% | — | — | |
| Q4 2015 | -9.1% | — | — | |
| Q3 2015 | +2.4% | — | — | |
| Q2 2015 | -4.7% | — | — | |
| Q1 2015 | +0.0% | — | — | |
| Q4 2014 | -8.6% | — | — | |
| Q3 2014 | -5.5% | — | — | |
| Q2 2014 | -0.6% | — | — | |
| Q1 2014 | -9.8% | — | — | |
| Q4 2013 | +4.0% | — | — | |
| Q3 2013 | +3.5% | — | — | |
| Q2 2013 | -7.9% | — | — | |
| Q1 2013 | -1.6% | — | — | |
| Q4 2012 | -1.8% | — | — | |
| Q3 2012 | +2.2% | — | — | |
| Q2 2012 | -1.9% | — | — | |
| Q1 2012 | +22.3% | — | — | |
| Q4 2011 | -10.1% | — | — | |
| Q3 2011 | -11.8% | — | — | |
| Q2 2011 | -37.3% | — | — | |
| Q1 2011 | +17.4% | — | — | |
| Q4 2010 | -6.8% | — | — | |
| Q3 2010 | +0.0% | — | — | |
| Q2 2010 | +2.9% | — | — | |
| Q1 2010 | -17.9% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro